På svenska
6/18/08 BioInvent and ThromboGenics announce a strategic alliance...

6/3/08 BioInvent and ThromboGenics report positive Phase I resul...

4/14/08 BioInvent International AB Annual General Meeting

BioInvent develops antibody drugs
BioInvent is a research-based pharmaceutical company that focuses on developing antibody drugs. The Company is currently running innovative drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases.

spacer